RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN
Clinical trial NCT01009346 · TERMINATED
Trial details
- NCT number
- NCT01009346
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.